Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,597 | 484 | 96.8% |
| Consulting Fee | $277.43 | 1 | 3.1% |
| Education | $7.75 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,594 | 116 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,534 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $512.07 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $481.24 | 16 | $0 (2024) |
| Mylan Specialty L.P. | $468.21 | 32 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $395.25 | 26 | $0 (2024) |
| GENZYME CORPORATION | $298.08 | 15 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $293.32 | 20 | $0 (2024) |
| bioMerieux Inc | $277.43 | 1 | $0 (2022) |
| Genentech USA, Inc. | $265.80 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,666 | 91 | GlaxoSmithKline, LLC. ($468.94) |
| 2023 | $1,180 | 64 | AstraZeneca Pharmaceuticals LP ($255.26) |
| 2022 | $1,886 | 88 | GlaxoSmithKline, LLC. ($374.42) |
| 2021 | $913.25 | 46 | AstraZeneca Pharmaceuticals LP ($162.64) |
| 2020 | $493.97 | 34 | Jazz Pharmaceuticals Inc. ($70.83) |
| 2019 | $1,219 | 68 | GlaxoSmithKline, LLC. ($149.28) |
| 2018 | $691.69 | 47 | GlaxoSmithKline, LLC. ($140.36) |
| 2017 | $832.64 | 48 | AstraZeneca Pharmaceuticals LP ($211.80) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Pulmonology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: HFCWO | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,304 | 1,672 | $493,493 | $160,929 |
| 2022 | 18 | 1,350 | 1,763 | $507,611 | $170,271 |
| 2021 | 20 | 1,469 | 2,009 | $540,918 | $185,103 |
| 2020 | 24 | 1,588 | 2,308 | $429,589 | $235,725 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 97 | 213 | $126,948 | $38,490 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 374 | $106,216 | $37,911 | 35.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 184 | 272 | $44,877 | $18,352 | 40.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 129 | $31,197 | $13,035 | 41.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 97 | 97 | $39,285 | $9,798 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 55 | $21,725 | $7,609 | 35.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 62 | $18,042 | $6,881 | 38.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $17,200 | $5,916 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $14,600 | $5,146 | 35.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 50 | 50 | $19,500 | $4,999 | 25.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 100 | 102 | $16,388 | $3,665 | 22.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 68 | 68 | $12,580 | $3,420 | 27.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 63 | 63 | $9,135 | $2,422 | 26.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 36 | 36 | $7,200 | $1,106 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $3,200 | $1,030 | 32.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 40 | 40 | $4,800 | $960.00 | 20.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 13 | 15 | $600.00 | $189.00 | 31.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 83 | 195 | $116,220 | $36,002 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 310 | $88,040 | $32,560 | 37.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 184 | 298 | $46,190 | $17,971 | 38.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 160 | $35,360 | $13,928 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 87 | $34,365 | $13,145 | 38.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 90 | 91 | $36,855 | $9,508 | 25.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $20,167 | $7,786 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $16,995 | $6,584 | 38.7% |
About Dr. Michael Driscoll, D.O
Dr. Michael Driscoll, D.O is a Critical Care Medicine healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497946792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Driscoll, D.O has received a total of $8,883 in payments from pharmaceutical and medical device companies, with $1,666 received in 2024. These payments were reported across 486 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,597).
As a Medicare-enrolled provider, Driscoll has provided services to 5,711 Medicare beneficiaries, totaling 7,752 services with total Medicare billing of $752,027. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Cherry Hill, NJ
- Active Since 08/05/2007
- Last Updated 05/05/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1497946792
Products in Payments
- DUPIXENT (Biological) $696.71
- TRELEGY ELLIPTA (Drug) $588.72
- NUCALA (Biological) $579.50
- BREZTRI (Drug) $365.21
- FASENRA (Biological) $338.77
- STIOLTO RESPIMAT (Drug) $287.59
- SYMBICORT (Drug) $272.86
- Yupelri (Drug) $271.76
- TEZSPIRE (Biological) $258.73
- FLOWTRIEVER CATHETER, S (Device) $234.51
- ORENITRAM (Drug) $211.24
- XYWAV (Drug) $199.13
- OFEV (Drug) $183.88
- UPTRAVI (Drug) $181.65
- ANORO (Drug) $178.29
- SMARTVEST (Device) $174.78
- Xolair (Biological) $168.67
- YUPELRI (Drug) $164.24
- WAKIX (Drug) $158.28
- (8874) inCourage (Device) $152.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Cherry Hill
William Morowitz, Md, MD
Critical Care Medicine — Payments: $5,004
Carol Mcdougall, Apn-C, APN-C
Critical Care Medicine — Payments: $863.00
Melissa Frucci
Critical Care Medicine — Payments: $536.61
Tara Potts
Critical Care Medicine